Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms

Clinical trial NCT00079989 · COMPLETED

Trial details

NCT number: NCT00079989
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gram-Negative Bacterial Infections

Start date: 2003-12-01
Primary completion: 2005-11-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.